Reuters logo
BRIEF-ThromboGenics cash and investments up at 113.4 million euros
October 20, 2017 / 5:54 AM / 2 months ago

BRIEF-ThromboGenics cash and investments up at 113.4 million euros

Oct 20 (Reuters) - THROMBOGENICS NV:

* CASH AND INVESTMENTS €113.4 MILLION AS OF END OF SEPT. 2017 VERSUS €65.1 MILLION AT END OF JUNE 2017‍​

* ANNOUNCES NOVARTIS WILL INVEST €10 MILLION IN THROMBOGENICS CAPITAL Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below